News
EBS
7.98
+1.66%
0.13
Weekly Report: what happened at EBS last week (0615-0619)?
Weekly Report · 1d ago
Weekly Report: what happened at EBS last week (0608-0612)?
Weekly Report · 06/15 09:58
Emergent BioSolutions: Down 40%+ From Recent Highs And Likely More To Come
Seeking Alpha · 06/08 21:27
Weekly Report: what happened at EBS last week (0601-0605)?
Weekly Report · 06/08 09:55
Emergent BioSolutions Supports Victoria’s Voice Foundation’s National Naloxone Awareness Day to Help Save Lives from Opioid Overdose
Barchart · 06/04 07:02
These 10 small-cap U.S. healthcare giants rank among the market's most attractively valued stocks
Seeking Alpha · 06/01 14:20
Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Emergent Biosolutions (EBS) and Compass Therapeutics (CMPX)
TipRanks · 06/01 10:30
Weekly Report: what happened at EBS last week (0525-0529)?
Weekly Report · 06/01 09:58
Emergent BioSolutions Gets $64.5M Contract Modification From HHS for Botulism Treatment
Dow Jones · 05/28 21:02
Emergent BioSolutions awarded $64.5M HHS contract modification
TipRanks · 05/28 21:00
Emergent BioSolutions Wins $64.5M U.S. HHS Contract Modification To Supply Botulism Antitoxin BAT Under Existing 10-Year Agreement
Benzinga · 05/28 20:22
Weekly Report: what happened at EBS last week (0518-0522)?
Weekly Report · 05/25 10:00
Emergent BioSolutions to Participate in Upcoming Investor Conferences
Barchart · 05/20 06:30
U.S. CDC Says Will Enhance Screening And Monitoring Of Travelers Arriving From Areas Affected By Ebola Outbreaks; Will Coordinate With Airlines, Others To Manage Travelers Who May Have Already Been Exposed To Ebola; Will Enhance Contract Tracing, Hospital Readiness Nationwide
Benzinga · 05/18 15:25
Emergent BioSolutions receives Saudi approval for ACAM2000 vaccine
TipRanks · 05/18 13:18
Emergent BioSolutions Announces Saudi Approval For ACAM2000, Its Smallpox and Mpox Vaccine
Benzinga · 05/18 13:02
Weekly Report: what happened at EBS last week (0511-0515)?
Weekly Report · 05/18 10:00
Weekly Report: what happened at EBS last week (0504-0508)?
Weekly Report · 05/11 09:58
Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Artiva Biotherapeutics, Inc. (ARTV) and Emergent Biosolutions (EBS)
TipRanks · 05/04 10:30
Weekly Report: what happened at EBS last week (0427-0501)?
Weekly Report · 05/04 09:57
More
Webull provides a variety of real-time EBS stock news. You can receive the latest news about Emergent Biosolutions Inc through multiple platforms. This information may help you make smarter investment decisions.
About EBS
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing services portfolio. Its segments include Commercial Products, MCM Products, and Services segment. Its Commercial Product segment consists of NARCAN Nasal Spray. Its MCM Products segment consists of Anthrax MCM products, Smallpox MCM products and Other Products. Its Services segment consists of its Bioservices portfolio. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone, is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and central nervous system depression. Its Bioservices consist of development services, bulk drug substance manufacturing, fill, finish, and packaging of final drug products.